Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in Amyotrophic Lateral Sclerosis
NCT02588677Phase 3Completed
- Sponsor
- AB Science
- Start
- Apr 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of masitinib in amyotrophic lateral sclerosis (ALS), sponsored by AB Science. Started Apr 2013; status: completed.
02
Drugs
masitinib
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT02588677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02588677.